Evidence map›Paper›PMID 29861845›Full record

ArticleOncotarget2018

Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.

Aparna Karthikeyan, Neelima Gupta, Carol Tang, Karthik Mallilankaraman, Maskomani Silambarasan, Meng Shi, Lei Lu, Beng Ti Ang, Eng-Ang Ling, S Thameem Dheen

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MiRNA-146a-A Key Player in Immunity and Diseases.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Aparna KarthikeyanDepartment of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Neelima GuptaDepartment of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Carol TangDepartment of Research, National Neuroscience Institute, Singapore.
Karthik MallilankaramanDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Maskomani SilambarasanDepartment of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Meng ShiSchool of Biological Sciences, Nanyang Technological University, Singapore.
Lei LuSchool of Biological Sciences, Nanyang Technological University, Singapore.
Beng Ti AngDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Eng-Ang LingDepartment of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
S Thameem DheenDepartment of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
National University of Singapore · SGNanyang Technological University · SGDuke-NUS Medical School · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioma tumors constitute a significant portion of microglial cells, which are known to support tumor progression. The present study demonstrates that transforming growth factor-β (TGFβ) signaling pathway in microglia in a glioma environment is involved in tumor progression and pathogenesis. It has been shown that the TGFβ level is elevated in higher grades of gliomas and its signaling pathway regulates tumor progression through phosphorylation of SMAD2 and SMAD3, which form a complex with SMAD4 to regulate target gene transcription. In an

Indexed as

gliomamicrogliamicroRNA-146aSMAD4TGFβ

Identifiers

PMID29861845
PMCPMC5982777
OpenAlexW2804162972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.